Frontiers The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Frontiers Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
Hutch News Fred Hutchinson Cancer Center
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment, Journal of Experimental & Clinical Cancer Research
Hutch News Fred Hutchinson Cancer Center
Immunotherapy for pancreatic cancer — science driving clinical progress
Crafting a better T cell for immunotherapy
Frontiers Innate immunity in pancreatic cancer: Lineage tracing and function
Hutch News Fred Hutchinson Cancer Center
The application of nanoparticles-based ferroptosis, pyroptosis and
Leveraging Immunogenic Cell Death in Pancreatic Cancer
Cancers, Free Full-Text
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Frontiers Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds